Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$7.11 USD
-0.79 (-10.00%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $7.10 -0.01 (-0.14%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | 2.22% |
ABR | 1.50 |
Earnings ESP
|
0.71% |
---|---|
Current Year | -1.64 |
Next Year | -1.47 |
EPS (TTM) | -2.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 1.69M | 18.27M |
# of Estimates | NA | NA | 4 | 2 |
High Estimate | NA | NA | 5.00M | 35.80M |
Low Estimate | NA | NA | 0.59M | 0.74M |
Year ago Sales | 0.00M | 0.00M | NA | 1.69M |
Year over Year Growth Est. | NA | NA | NA | 979.73% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.40 | -1.64 | -1.47 |
# of Estimates | 7 | 6 | 8 | 8 |
Most Recent Consensus | -0.40 | -0.40 | -1.68 | -1.45 |
High Estimate | -0.37 | -0.34 | -1.46 | -1.13 |
Low Estimate | -0.43 | -0.45 | -1.82 | -1.71 |
Year ago EPS | -0.47 | -0.55 | -2.03 | -1.64 |
Year over Year Growth Est. | 14.89% | 27.27% | 19.21% | 10.44% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.40 | -1.64 | -1.47 |
7 Days Ago | -0.40 | -0.40 | -1.64 | -1.47 |
30 Days Ago | -0.40 | -0.40 | -1.64 | -1.48 |
60 Days Ago | -0.44 | -0.45 | -1.80 | -1.65 |
90 Days Ago | -0.44 | -0.45 | -1.83 | -1.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.40 | -1.65 | -1.44 |
Zacks Consensus Estimate | -0.40 | -0.40 | -1.64 | -1.47 |
Earnings ESP | 0.71% | 0.42% | -0.46% | 2.47% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.56 | -0.55 | -0.47 | NA |
Estimate | -0.45 | -0.48 | -0.45 | -0.42 | NA |
Difference | 0.01 | -0.08 | -0.10 | -0.05 | -0.06 |
Surprise | 2.22% | -16.67% | -22.22% | -11.90% | -12.14% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more